Matches in SemOpenAlex for { <https://semopenalex.org/work/W3155482839> ?p ?o ?g. }
- W3155482839 endingPage "e0250597" @default.
- W3155482839 startingPage "e0250597" @default.
- W3155482839 abstract "Tacrolimus (Tac) is an effective remission inducer of refractory ulcerative colitis (UC). Gene polymorphisms result in interindividual variability in Tac pharmacokinetics. In this study, we aimed to examine the relationships between gene polymorphisms and the metabolism, pharmacokinetics, and therapeutic effects of Tac in patients with UC. Forty-five patients with moderate-to-severe refractory UC treated with Tac were retrospectively enrolled. Genotyping for cytochrome P450 ( CYP ) 3A4*1G , CYP3A5*3 , CYP2C19*2 , CYP2C19*3 , nuclear receptor subfamily 1 group I member 2 ( NR1I2 ) –25385C>T , ATP-binding cassette subfamily C member 2 ( ABCC2 ) –24C>T , ABCC2 1249G>A , and ABCC2 3972C>T was performed. Concentration/dose (C/D) ratio, clinical therapeutic effects, and adverse events were evaluated. The C/D ratio of Tac in UC patients with the CYP3A4*1G allele was statistically lower than in those with the CYP3A4*1 /* 1 allele (P = 0.005) and significantly lower in patients with CYP3A5*3 /* 3 than in those with CYP3A5*1 (P < 0.001). Among patients with the CYP3A4*1G allele, the C/D ratio was significantly lower in patients with CYP3A5*1 than in those with CYP3A5*3 /* 3 (P = 0.001). Patients with the NR1I2–25385C/C genotype presented significantly more overall adverse events than those with the C/T or T/T genotype (P = 0.03). Although CYP3A4*1G and CYP3A5*3 polymorphisms were related to Tac pharmacokinetics, CYP3A5 presented a stronger effect than CYP3A4 . The NR1I2–25385C/C genotype was related to the overall adverse events. The evaluation of these polymorphisms could be useful in the treatment of UC with Tac." @default.
- W3155482839 created "2021-04-26" @default.
- W3155482839 creator A5006230546 @default.
- W3155482839 creator A5007739209 @default.
- W3155482839 creator A5007977679 @default.
- W3155482839 creator A5029752941 @default.
- W3155482839 creator A5039509783 @default.
- W3155482839 creator A5045329864 @default.
- W3155482839 creator A5053569012 @default.
- W3155482839 creator A5060186217 @default.
- W3155482839 creator A5061716873 @default.
- W3155482839 creator A5075849177 @default.
- W3155482839 creator A5080368045 @default.
- W3155482839 creator A5082786277 @default.
- W3155482839 creator A5086166261 @default.
- W3155482839 creator A5087753310 @default.
- W3155482839 date "2021-04-22" @default.
- W3155482839 modified "2023-10-01" @default.
- W3155482839 title "The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients" @default.
- W3155482839 cites W1564474120 @default.
- W3155482839 cites W1847079687 @default.
- W3155482839 cites W1890529144 @default.
- W3155482839 cites W1952558609 @default.
- W3155482839 cites W1953980217 @default.
- W3155482839 cites W1964698840 @default.
- W3155482839 cites W1972740140 @default.
- W3155482839 cites W1977003280 @default.
- W3155482839 cites W1984615841 @default.
- W3155482839 cites W1987600922 @default.
- W3155482839 cites W1992188999 @default.
- W3155482839 cites W2007469043 @default.
- W3155482839 cites W2015968334 @default.
- W3155482839 cites W2031193040 @default.
- W3155482839 cites W2033139608 @default.
- W3155482839 cites W2035144264 @default.
- W3155482839 cites W2040923457 @default.
- W3155482839 cites W2059318722 @default.
- W3155482839 cites W2061099365 @default.
- W3155482839 cites W2066405947 @default.
- W3155482839 cites W2068489442 @default.
- W3155482839 cites W2070092889 @default.
- W3155482839 cites W2076454486 @default.
- W3155482839 cites W2087775788 @default.
- W3155482839 cites W2088250393 @default.
- W3155482839 cites W2089892642 @default.
- W3155482839 cites W2095792627 @default.
- W3155482839 cites W2105902511 @default.
- W3155482839 cites W2115061192 @default.
- W3155482839 cites W2127624886 @default.
- W3155482839 cites W2140510610 @default.
- W3155482839 cites W2143710323 @default.
- W3155482839 cites W2164539379 @default.
- W3155482839 cites W2182240278 @default.
- W3155482839 cites W2200172641 @default.
- W3155482839 cites W2345433402 @default.
- W3155482839 cites W2523408122 @default.
- W3155482839 cites W2582040366 @default.
- W3155482839 cites W2595057936 @default.
- W3155482839 cites W2759783253 @default.
- W3155482839 cites W2802354900 @default.
- W3155482839 cites W2808523271 @default.
- W3155482839 cites W2902458742 @default.
- W3155482839 cites W2913542523 @default.
- W3155482839 cites W2915390140 @default.
- W3155482839 cites W3016171703 @default.
- W3155482839 cites W4211138554 @default.
- W3155482839 doi "https://doi.org/10.1371/journal.pone.0250597" @default.
- W3155482839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8062093" @default.
- W3155482839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33886687" @default.
- W3155482839 hasPublicationYear "2021" @default.
- W3155482839 type Work @default.
- W3155482839 sameAs 3155482839 @default.
- W3155482839 citedByCount "3" @default.
- W3155482839 countsByYear W31554828392021 @default.
- W3155482839 countsByYear W31554828392022 @default.
- W3155482839 countsByYear W31554828392023 @default.
- W3155482839 crossrefType "journal-article" @default.
- W3155482839 hasAuthorship W3155482839A5006230546 @default.
- W3155482839 hasAuthorship W3155482839A5007739209 @default.
- W3155482839 hasAuthorship W3155482839A5007977679 @default.
- W3155482839 hasAuthorship W3155482839A5029752941 @default.
- W3155482839 hasAuthorship W3155482839A5039509783 @default.
- W3155482839 hasAuthorship W3155482839A5045329864 @default.
- W3155482839 hasAuthorship W3155482839A5053569012 @default.
- W3155482839 hasAuthorship W3155482839A5060186217 @default.
- W3155482839 hasAuthorship W3155482839A5061716873 @default.
- W3155482839 hasAuthorship W3155482839A5075849177 @default.
- W3155482839 hasAuthorship W3155482839A5080368045 @default.
- W3155482839 hasAuthorship W3155482839A5082786277 @default.
- W3155482839 hasAuthorship W3155482839A5086166261 @default.
- W3155482839 hasAuthorship W3155482839A5087753310 @default.
- W3155482839 hasBestOaLocation W31554828391 @default.
- W3155482839 hasConcept C104317684 @default.
- W3155482839 hasConcept C109650736 @default.
- W3155482839 hasConcept C112705442 @default.
- W3155482839 hasConcept C126322002 @default.
- W3155482839 hasConcept C135763542 @default.
- W3155482839 hasConcept C140840227 @default.